Back
scPharmaceuticals Vs. Verrica Pharmaceuticals Industry Stock Comparison
Sell
27
SCPH
scPharmaceuticals
Last Price:
5.26
Seasonality Move:
-14.35%
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
1.94
Seasonality Move:
-10.89%
Sell
27
scPharmaceuticals (SCPH)
is a Sell
Is scPharmaceuticals a Buy, Sell or Hold?
- The current scPharmaceuticals [SCPH] share price is $5.43. The Score for SCPH is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- SCPH is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
- The current Verrica Pharmaceuticals [VRCA] share price is $1.86. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SCPH Stock Price Chart
What is scPharmaceuticals's stock price today?
-
The scPharmaceuticals share price today is $5.43
The current trend is moderately bullish and SCPH is experiencing selling pressure, which indicates risk of future bearish movement.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $1.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.
SCPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.16 | Buy |
Relative Strength Index (14 RSI): | 59.53 | Buy |
Chaikin Money Flow: | 108926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 23.71 | Sell |
Chaikin Money Flow: | -76106 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SCPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.3 | Buy |
20-day SMA: | 5.2 | Buy |
50-day SMA: | 4.91 | Buy |
200-day SMA: | 5.04 | Buy |
8-day EMA: | 5.35 | Buy |
20-day EMA: | 5.19 | Buy |
50-day EMA: | 4.95 | Buy |
200-day EMA: | 5.18 | Buy |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.9 | Sell |
20-day SMA: | 2.22 | Sell |
50-day SMA: | 4.56 | Sell |
200-day SMA: | 5.99 | Sell |
8-day EMA: | 1.93 | Sell |
20-day EMA: | 2.44 | Sell |
50-day EMA: | 3.96 | Sell |
200-day EMA: | 5.56 | Sell |
scPharmaceuticals Earnings Growth & SCPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.13 per share, an increase this year of $0.14 per share, and an increase next year of $0.55 per share.
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.
scPharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Verrica Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |